<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, E7777 was given for a median of three cycles (range, 1‐8), with six patients receiving ≥4 cycles and one patient receiving all 8 cycles. Four patients (31%) discontinued treatment because of disease progression, and three (23%) and five patients (38%) withdrew because of AEs or personal decisions/other reasons, respectively.</p>
